EMED (Electromedical Technologies) EBITDA Margin %: -1,527.91% (As of Sep. 2024)


What is Electromedical Technologies EBITDA Margin %?

Electromedical Technologies EMED EBITDA Margin % is -1,527.91% as of Sep. 2024.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Electromedical Technologies's EBITDA for the three months ended in Sep. 2024 was $-0.66 Mil. Electromedical Technologies's Revenue for the three months ended in Sep. 2024 was $0.04 Mil. Therefore, Electromedical Technologies's EBITDA margin for the quarter that ended in Sep. 2024 was -1,527.91%.

Electromedical Technologies  (OTCPK:EMED) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Electromedical Technologies EBITDA Margin % Related Terms

Electromedical Technologies EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Electromedical Technologies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Electromedical Technologies EBITDA Margin % Chart

Electromedical Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
-200.60 -417.34 -567.14 -230.96 -127.65

Electromedical Technologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.51 -77.84 -263.79 126.47 -1,527.91

EMED vs DYNT, SONX, USAQ: EBITDA Margin % Comparison

For the Medical Devices subindustry, Electromedical Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Electromedical Technologies EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromedical Technologies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Electromedical Technologies's EBITDA Margin % falls into.


Electromedical Technologies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Electromedical Technologies's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-1.722/1.349
=-127.65 %

Electromedical Technologies's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-0.657/0.043
=-1,527.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -1,527.91% mean?
Electromedical Technologies (EMED) has a EBITDA Margin % of -1,527.91% as of Sep. 2024. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Electromedical Technologies and its competitors.
Is Electromedical Technologies' EBITDA Margin % too high?
Electromedical Technologies' current EBITDA Margin % is -1,527.91%.
How does Electromedical Technologies' EBITDA Margin % compare to DYNT and SONX?
Electromedical Technologies' EBITDA Margin % of -1,527.91% can be compared against companies in the Medical Devices & Instruments industry. The industry median EBITDA Margin % is 7.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.44, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Electromedical Technologies and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Electromedical Technologies's current EBITDA Margin % is -1,527.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromedical Technologies stock overvalued right now?
Electromedical Technologies (EMED) has a current EBITDA Margin % of -1,527.91%. The current EBITDA Margin % is -1,527.91%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Electromedical Technologies (EMED), the current EBITDA Margin % is -1,527.91% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Electromedical Technologies Business Description

Address 10105 E. Via Linda, No. 103-300, Scottsdale, AZ, USA, 85258
Electromedical Technologies Inc is a Delaware-based bioelectronics manufacturing company. The company designs, develops, and markets FDA-cleared, non-invasive, and simple-to-use bioelectronics therapy medical devices that serve as drug-free alternatives for pain relief. The company's device provide immediate and long-lasting pain relief across the broadest range of ailments. It focuses on improving globalised wellness for people suffering from various painful conditions.